Role of 5a-reductase inhibitors and selective estrogen receptor modulators as potential chemopreventive agents for prostate cancer

Clin Prostate Cancer. 2005 Mar;3(4):211-4. doi: 10.1016/s1540-0352(11)70089-0.
No abstract available

MeSH terms

  • Antineoplastic Agents, Hormonal / administration & dosage
  • Chemoprevention
  • Cholestenone 5 alpha-Reductase / antagonists & inhibitors
  • Enzyme Inhibitors / administration & dosage
  • Finasteride / administration & dosage
  • Humans
  • Male
  • Prostatic Hyperplasia / prevention & control
  • Prostatic Neoplasms / prevention & control*
  • Randomized Controlled Trials as Topic
  • Selective Estrogen Receptor Modulators / administration & dosage
  • Toremifene / administration & dosage

Substances

  • Antineoplastic Agents, Hormonal
  • Enzyme Inhibitors
  • Selective Estrogen Receptor Modulators
  • Finasteride
  • Toremifene
  • Cholestenone 5 alpha-Reductase